RYTM logo

Rhythm Pharmaceuticals, Inc. (RYTM) Depreciation and amortization

annual D&A:

$1.56M-$195.00K(-11.09%)
December 31, 2024

Summary

  • As of today (September 9, 2025), RYTM annual depreciation & amortization is $1.56 million, with the most recent change of -$195.00 thousand (-11.09%) on December 31, 2024.
  • During the last 3 years, RYTM annual D&A has risen by +$405.00 thousand (+34.97%).
  • RYTM annual D&A is now -11.09% below its all-time high of $1.76 million, reached on December 31, 2023.

Performance

RYTM Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

quarterly D&A:

$379.00K-$4000.00(-1.04%)
June 30, 2025

Summary

  • As of today (September 9, 2025), RYTM quarterly depreciation & amortization is $379.00 thousand, with the most recent change of -$4000.00 (-1.04%) on June 30, 2025.
  • Over the past year, RYTM quarterly D&A has dropped by -$11.00 thousand (-2.82%).
  • RYTM quarterly D&A is now -31.22% below its all-time high of $551.00 thousand, reached on March 31, 2023.

Performance

RYTM quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

TTM D&A:

$1.53M-$11.00K(-0.71%)
June 30, 2025

Summary

  • As of today (September 9, 2025), RYTM TTM depreciation & amortization is $1.53 million, with the most recent change of -$11.00 thousand (-0.71%) on June 30, 2025.
  • Over the past year, RYTM TTM D&A has increased by +$68.00 thousand (+4.65%).
  • RYTM TTM D&A is now -23.80% below its all-time high of $2.01 million, reached on September 30, 2023.

Performance

RYTM TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

RYTM Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-11.1%-2.8%+4.7%
3 y3 years+35.0%+1.6%+17.9%
5 y5 years+87.4%+119.1%+111.9%

RYTM Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-11.1%+35.0%-31.2%+208.1%-23.8%+17.9%
5 y5-year-11.1%+126.5%-31.2%+208.1%-23.8%+121.7%
alltimeall time-11.1%>+9999.0%-31.2%>+9999.0%-23.8%>+9999.0%

RYTM Depreciation and amortization History

DateAnnualQuarterlyTTM
Jun 2025
-
$379.00K(-1.0%)
$1.53M(-0.7%)
Mar 2025
-
$383.00K(0.0%)
$1.54M(-1.4%)
Dec 2024
$1.56M(-11.1%)
$383.00K(-0.5%)
$1.56M(+20.0%)
Sep 2024
-
$385.00K(-1.3%)
$1.30M(-10.9%)
Jun 2024
-
$390.00K(-3.7%)
$1.46M(-9.3%)
Mar 2024
-
$405.00K(+229.3%)
$1.61M(-8.3%)
Dec 2023
$1.76M(+25.1%)
$123.00K(-77.4%)
$1.76M(-12.5%)
Sep 2023
-
$544.00K(+0.7%)
$2.01M(+9.2%)
Jun 2023
-
$540.00K(-2.0%)
$1.84M(+10.0%)
Mar 2023
-
$551.00K(+47.7%)
$1.67M(+18.9%)
Dec 2022
$1.41M(+21.3%)
$373.00K(-0.3%)
$1.41M(+3.5%)
Sep 2022
-
$374.00K(+0.3%)
$1.36M(+4.5%)
Jun 2022
-
$373.00K(+30.9%)
$1.30M(+4.5%)
Mar 2022
-
$285.00K(-12.3%)
$1.24M(+7.3%)
Dec 2021
$1.16M(+67.8%)
$325.00K(+3.2%)
$1.16M(+14.5%)
Sep 2021
-
$315.00K(-0.6%)
$1.01M(+16.5%)
Jun 2021
-
$317.00K(+57.7%)
$868.00K(+19.9%)
Mar 2021
-
$201.00K(+12.9%)
$724.00K(+4.9%)
Dec 2020
$690.00K
$178.00K(+3.5%)
$690.00K(-1.8%)
Sep 2020
-
$172.00K(-0.6%)
$703.00K(-2.6%)
DateAnnualQuarterlyTTM
Jun 2020
-
$173.00K(+3.6%)
$722.00K(-4.5%)
Mar 2020
-
$167.00K(-12.6%)
$756.00K(-9.4%)
Dec 2019
$834.00K(+88.7%)
$191.00K(0.0%)
$834.00K(-2.7%)
Sep 2019
-
$191.00K(-7.7%)
$857.00K(+11.0%)
Jun 2019
-
$207.00K(-15.5%)
$772.00K(+23.3%)
Mar 2019
-
$245.00K(+14.5%)
$626.00K(+41.6%)
Dec 2018
$442.00K(+98.2%)
$214.00K(+101.9%)
$442.00K(+53.5%)
Sep 2018
-
$106.00K(+73.8%)
$288.00K(+21.5%)
Jun 2018
-
$61.00K(0.0%)
$237.00K(+3.0%)
Mar 2018
-
$61.00K(+1.7%)
$230.00K(+3.1%)
Dec 2017
$223.00K(+54.9%)
$60.00K(+9.1%)
$223.00K(+36.8%)
Sep 2017
-
$55.00K(+1.9%)
$163.00K(+50.9%)
Jun 2017
-
$54.00K(0.0%)
$108.00K(+24.1%)
Mar 2017
-
$54.00K(+63.6%)
$87.00K(+163.6%)
Dec 2016
$144.00K(>+9900.0%)
-
-
Jun 2016
-
$33.00K(>+9900.0%)
$33.00K(>+9900.0%)
Mar 2016
-
$0.00
$0.00
Dec 2015
$0.00(-100.0%)
-
-
Dec 2013
$20.00K(+17.6%)
-
-
Dec 2012
$17.00K
-
-

FAQ

  • What is Rhythm Pharmaceuticals, Inc. annual depreciation & amortization?
  • What is the all time high annual D&A for Rhythm Pharmaceuticals, Inc.?
  • What is Rhythm Pharmaceuticals, Inc. annual D&A year-on-year change?
  • What is Rhythm Pharmaceuticals, Inc. quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Rhythm Pharmaceuticals, Inc.?
  • What is Rhythm Pharmaceuticals, Inc. quarterly D&A year-on-year change?
  • What is Rhythm Pharmaceuticals, Inc. TTM depreciation & amortization?
  • What is the all time high TTM D&A for Rhythm Pharmaceuticals, Inc.?
  • What is Rhythm Pharmaceuticals, Inc. TTM D&A year-on-year change?

What is Rhythm Pharmaceuticals, Inc. annual depreciation & amortization?

The current annual D&A of RYTM is $1.56M

What is the all time high annual D&A for Rhythm Pharmaceuticals, Inc.?

Rhythm Pharmaceuticals, Inc. all-time high annual depreciation & amortization is $1.76M

What is Rhythm Pharmaceuticals, Inc. annual D&A year-on-year change?

Over the past year, RYTM annual depreciation & amortization has changed by -$195.00K (-11.09%)

What is Rhythm Pharmaceuticals, Inc. quarterly depreciation & amortization?

The current quarterly D&A of RYTM is $379.00K

What is the all time high quarterly D&A for Rhythm Pharmaceuticals, Inc.?

Rhythm Pharmaceuticals, Inc. all-time high quarterly depreciation & amortization is $551.00K

What is Rhythm Pharmaceuticals, Inc. quarterly D&A year-on-year change?

Over the past year, RYTM quarterly depreciation & amortization has changed by -$11.00K (-2.82%)

What is Rhythm Pharmaceuticals, Inc. TTM depreciation & amortization?

The current TTM D&A of RYTM is $1.53M

What is the all time high TTM D&A for Rhythm Pharmaceuticals, Inc.?

Rhythm Pharmaceuticals, Inc. all-time high TTM depreciation & amortization is $2.01M

What is Rhythm Pharmaceuticals, Inc. TTM D&A year-on-year change?

Over the past year, RYTM TTM depreciation & amortization has changed by +$68.00K (+4.65%)
On this page